Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas

Abroad (travel likely)RecruitingPHASE2

Conditions

Glioblastoma, Recurrent · Lower Grade Glioma, Recurrent

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Sanbo Brain Hospital, Beijing, China
Contact: Study coordinator (Jun-ping Zhang) · doczhjp@hotmail.com · 86-010-62856798

Study leads

Jun-ping Zhang
Principal Investigator
Beijing Sanbo Brain Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

Glioma · Medulloblastoma · Ependymoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

Glioblastoma · Anaplastic Astrocytoma · Anaplastic Oligoastrocytoma

Abroad (travel likely)RecruitingPHASE2

New York, United States

Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)

Glioblastoma Multiforme · Glioblastoma · Glioma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Charlottesville, United States

A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

Glioblastoma Multiforme of Brain · Glioma · Glioblastoma

Abroad (travel likely)RecruitingPHASE1

Tampa, United States · Chicago, United States